Quantamental Technologies’s BlueLinx BXC Stock Holding History

Quantamental Technologies’s Portfolio BXC Stock Details BXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-835	Closed	-$27K	–	543
2019 Q3	$27K	Buy	+835	New	+$21.1K	0.01%	1136

Other funds holding BXC

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

AWW

Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Quantamental Technologies's BXC Position: Q4 2019 in Review

Quantamental Technologies sold out of BlueLinx (BXC) in Q4 2019, closing a stake of 835 shares — an estimated $27K sold.

Quantamental Technologies first reported a position in BXC in Q3 2019 and held it in 1 quarter. The position peaked at $27K in Q3 2019. 66 funds tracked by Wall St. Rank hold BXC as of Q4 2019.

Quantamental Technologies reported no remaining BlueLinx position as of Q4 2019 after selling out during the quarter.
Quantamental Technologies sold 835 BlueLinx shares in Q4 2019, an estimated $27K.
Quantamental Technologies first reported a position in BlueLinx in Q3 2019 and held it in 1 quarter.
Quantamental Technologies's BlueLinx position peaked at $27K in Q3 2019.
66 funds tracked by Wall St. Rank held BlueLinx as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.